Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
BIVI - BioVie Inc
-2.75(-8.21%)9:00:00 PM 2/24/2021
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which completed Phase 2a clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was founded in 2013 and is based in Santa Monica, California.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
PE Ratio
PEG Ratio
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %1%
Held by Institutions %0%
1 Day Vol Adjusted Return-0.8
1 Month Vol Adjusted Return-0.5
3 Month Vol Adjusted Return33.1
6 Month Vol Adjusted Return
20 Days SMA Price ZScore-1.5
50 Days SMA Price ZScore0.2
12 -26 Days PPO3.4
1 Month Average Short Volume Ratio50.9
1 Day Volume Change ZScore-0.8
1 Month Daily Vol10.9
Related Topics
leak data

Related Topics


Related Peers

Stock news